The HCPLive epilepsy page is a comprehensive resource for clinical news and insights on the seizure disorder. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for epileptic seizures, and more.
December 13th 2023
In recent conversations with experts in epilepsy, the impact of stigmatization remains high for patients and ongoing efforts by clinicians to address this issue in the clinical setting has been underscored, despite the global lack of awareness about new treatments and other resources.
November 28th 2019
First FDA-Approved Cannabinoid Medication Now Available in US by Prescription
Cannabidiol (Epidiolex), the first FDA-approved plant-derived cannabinoid medicine in the United States, is now available by prescription for patients with seizures associated with Lennox-Gastaut syndrome or Dravet syndrome.
Clobazam (SYMPAZAN) Oral Film Approved by FDA for Lennox-Gastaut Syndrome
Aquestive Therapeutics’ clobazam (SYMPAZAN) oral film has been approved by the US Food and Drug administration (FDA) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients aged 2 years or older.
Valproic Acid and Carbapenem Antibiotics Interaction
October 19th 2018The effect of a carbapenem on VPA is significant and may result in reduced efficacy and increased seizure activity. Because of the mechanism of this interaction, increasing the dose of the VPA will unlikely achieve therapeutic plasma concentrations.